United Nations Development Programme
The United Nations Development Programme (UNDP) is the UN’s global development network, advocating for change and connecting countries to knowledge, experience, and resources to help people build a better life. We are on the ground in 170 countries and territories, working with governments and people on their own solutions to global and national development challenges to help empower lives and build resilient nations.
UNDP contributes to public health and development partnerships through collaborations with the Global Fund to Fight AIDS, Tuberculosis and Malaria (the ‘Global Fund’), Roll Back Malaria, Stop TB Partnerships, and special programmes on human reproduction and infectious diseases that disproportionately affect poor populations. As part of its wider engagement with the United Nations, the Global Fund has partnered with UNDP since 2003 to ensure that grants are implemented, and services are delivered in countries facing complex challenges. The partnership focuses on three closely linked areas of work: implementation support, capacity development, and policy engagement.
For implementation support UNDP serves as an interim Principal Recipient (PR) (currently in 25 countries) in a variety of settings including countries that face capacity constraints, complex emergencies, poor governance environments, political upheaval, or donor sanctions. It does so upon request by the Global Fund and/or the Country Coordinating Mechanism (CCM) and when no national entity is able to assume the role at the time. UNDP’s role as PR is an interim arrangement until national entities can assume full responsibility for implementation and the capacity of national partners (Government and CSOs) is also strengthened to ensure long-term sustainability of health outcomes.
The Pacific Islands Regional Multi-Country Coordinating Mechanism (PIRMCCM) has entrusted the United Nations Development Programme (UNDP) to serve as the PR for Grant Cycle (GC7) from the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). The three-year (2024- 2026) grant cycle aims to strengthen national responses to HIV and tuberculosis (TB) in the Western Pacific region.
The Multi-Country Western Pacific Integrated HIV/TB Programme supports national and regional efforts across 12 Pacific islands countries (PICs): Cook Islands, Fiji, Federal State of Micronesia, Kiribati, Republic of the Marshall Islands, Nauru, Niue, Palau, Samoa, Tonga, Tuvalu and Vanuatu to scale up and improve the delivery of human immunodeficiency virus (HIV) and tuberculosis (TB) prevention, treatment, care and support services, with special attention to key and vulnerable population groups, and to mitigate against the emerging emergency health risks.
The programme objective is to:
1. Strengthen comprehensiveness and quality of HIV prevention, treatment and care service-delivery models with a view to programmatic sustainability.
2. Provide early rapid and quality diagnosis of TB, DR-TB and comorbidities with specific focus on hard to reach, vulnerable groups across 12 Pacific Island countries.
3. Sustain high quality treatment for all forms of TB including drug-resistant TB and HIV-related TB with patient support; and 4) build up the resilience of healthcare systems, including community systems, to deliver integrated people-centered models of HIV and TB care.
This Terms of Reference outlines activities of the Bio-Behavioral Surveillance Surveys including population size estimates in Fiji. It presents the objectives, expected results, scope of consultant’s services, responsibilities, consultant profile, reporting requirements and dissemination of HIV surveillance activities in Fiji to strengthen epidemic and program intelligence. This includes bio-behavioral surveillance surveys among Sex Workers (SW), Men Who have Sex with Men (MSM) and transgender (TG).
The general objective of the study is to determine the prevalence of HIV and risk behavior among SW, MSM and TG and to estimate the size of these key populations. It will also provide information on the locations and size of the SW, MSM and TG. Additionally, the study will provide estimates of the prevalence of HIV, Syphilis, hepatitis (B and C), Chlamydia and Gonorrhea. It is also designed to provide information on the utilization of risk reduction services, and changes in knowledge, attitudes, and practices about HIV. This information will help inform prevention and intervention activities for these populations and measure their success in reaching these sub-populations. An understanding of HIV burden, risk factors, and coverage of prevention and treatment services is critical for combatting the HIV epidemic. This biobehavioral survey will assess these parameters which are integral components of the national HIV strategy and surveillance system.
If you already have a supplier profile, please login to the Supplier Portal, then search for the negotiation using the reference number UNDP-FJI-00460, following the instructions in the user guide.
To help us track our procurement effort, please indicate in your emall where (globalvacancies.org) you saw this tender/procurement notice.